Daisy Shaw

Ms. Daisy Shaw

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in Trends in Parasitology
Verified
Journal Article
Open access
ATAnastasios D. Tsaousis
Anastasios D. Tsaousis
DSDaisy Shaw
Daisy Shaw
KJKaterina Jirku
Katerina Jirku
David CarmenaDavid Carmena
David Carmena
EGEleni Gentekaki
Eleni Gentekaki
Blastocystis, a prevalent eukaryote in human stool, may represent a core but cyclically abundant gut resident rather than a sporadic microorganism. Its fluctuating detectability might reflect host-microbe-environment dynamics and diagnostic limitations. Longitudinal sampling and advanced detection methods are essential to elucidate its ecological role and clinical significance.

20 January 2025 in Open Research Europe
Verified
Journal Article
Open access
Ana M. FigueiredoAna M. Figueiredo
Ana M. Figueiredo
DSDaisy Shaw
Daisy Shaw
VTVarol TUNALI
Varol TUNALI
EGEleni Gentekaki
Eleni Gentekaki
ATAnastasios D. Tsaousis
Anastasios D. Tsaousis
David CarmenaDavid Carmena
David Carmena
While the stramenopile Blastocystis, first discovered in 1911, is considered the most prevalent enteric protist in humans, its biology remains largely unexplored. Clinical studies have only recently begun investigating the role of Blastocystis in the gut and its relationship with the gut microbiome, and whether it plays a pathogenic role in human and animal health. Aiming to gather leading researchers in the field to encourage and stimulate cross-disciplinary dialogue while fostering long-term international collaborations, the Fourth International Blastocystis Conference was hosted from the 17 th to the 19 th of September 2024 in Heraklion (Crete, Greece). The event was mainly supported by the COST Action CA21105, “ Blastocystis under One Health”, and the Microbiology Society. The multi- and interdisciplinary conference programme covered all aspects related to Blastocystis evolutionary biology and advances in omics, intestinal ecology (gut microbiome), clinical significance and association with disease, diagnosis and molecular characterisation, as well as epidemiology and One Health. The high-quality presentations discussed at the conference provided researchers with a synthesis of recent advancements, while key research questions, knowledge gaps, and future steps in Blastocystis research were identified. Herein, we aim to provide a thorough overview of the presentations at the congress. The COST Action CA21105, 'Blastocystis under One Health,' will build on the insights and collaborations fostered during the conference, promoting integrative research approaches, advancing our understanding of Blastocystis, and driving future efforts to translate these findings into improved public health strategies.

14 August 2025 in Current Protocols
Verified
Journal Article
Open access
DSDaisy Shaw
Daisy Shaw
CDConstance Denoyelle
Constance Denoyelle
KTKevin S.w. Tan
Kevin S.w. Tan
CCC. Graham Clark
C. Graham Clark
HYHisao Yoshikawa
Hisao Yoshikawa
ATAnastasios D. Tsaousis
Anastasios D. Tsaousis
Blastocystis spp. is a widely prevalent anaerobic protozoan of uncertain pathogenicity found in the gastrointestinal tracts of over 1 billion people worldwide. Despite its potential significance in health and disease, Blastocystis spp. remains challenging to culture axenically due to its anaerobic nature and the diversity of its genetic subtypes. This manuscript presents a standardized toolkit for culturing Blastocystis spp. in xenic and axenic conditions, detailing protocols for the preparation of appropriate liquid and solid media, cryopreservation, and inoculation. By providing a comprehensive set of tools and methodologies, this work aims to streamline research on Blastocystis spp., enabling reproducibility, subtype characterization, and advancements in understanding its role in the gut microbiome and host health. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Establishment of xenic Blastocystis culture from stool samples in liquid mediumBasic Protocol 2: Subculturing from existing Blastocystis liquid cultureSupport Protocol 1: Preparation of modified Jones’ medium for Blastocystis culturingSupport Protocol 2: Preparation of trypticase‐yeast extract‐serum‐gastric mucin‐9 (TSGYM‐9) medium for Blastocystis culturingSupport Protocol 3: Preparation of liver extract‐yeast extract‐serum‐gastric mucin (LYSGM) medium for Blastocystis culturingBasic Protocol 3: Subculturing xenic Blastocystis cultures in diphasic mediumSupport Protocol 4: Preparation of Robinson's medium for Blastocystis culturingSupport Protocol 5: Preparation of Ringer's agar slants for Blastocystis culturingBasic Protocol 4: Axenization of Blastocystis culturesBasic Protocol 5: Subculturing axenic Blastocystis cultures in diphasic mediumSupport Protocol 6: Preparation of Boeck and Drbohlav's Locke‐egg serum (LES) medium for Blastocystis culturingSupport Protocol 7: Preparation of Boeck and Drbohlav's diphasic modified medium (BDMM) for Blastocystis culturingBasic Protocol 6: Establishment of axenic Blastocystis cultures in Iscove's modified Dulbecco's medium (IMDM)Basic Protocol 7: Establishment of axenic Blastocystis cultures in soft IMDM agarBasic Protocol 8: Establishment of axenic Blastocystis cultures on solid IMDM agarBasic Protocol 9: Optimized method for establishing axenic Blastocystis cultures on solid IMDM agarBasic Protocol 10: Establishment of axenic Blastocystis cultures in semi‐solid Locke's agarBasic Protocol 11: Cryopreservation of xenic Blastocystis culturesBasic Protocol 12: Cryopreservation of axenic Blastocystis culturesBasic Protocol 13: Inoculation of liquid medium with xenic Blastocystis cultures from frozen stocksBasic Protocol 14: Inoculation of liquid medium with axenic Blastocystis cultures from frozen stocks

7 March 2025 in Open Research Europe
Verified
Journal Article
Open access
Ana M. FigueiredoAna M. Figueiredo
Ana M. Figueiredo
DSDaisy Shaw
Daisy Shaw
VTVarol TUNALI
Varol TUNALI
EGEleni Gentekaki
Eleni Gentekaki
ATAnastasios D. Tsaousis
Anastasios D. Tsaousis
David CarmenaDavid Carmena
David Carmena
While the stramenopile Blastocystis, first discovered in 1911, is considered the most prevalent enteric protist in humans, its biology remains largely unexplored. Clinical studies have only recently begun investigating the role of Blastocystis in the gut and its relationship with the gut microbiome, and whether it plays a pathogenic role in human and animal health. Aiming to gather leading researchers in the field to encourage and stimulate cross-disciplinary dialogue while fostering long-term international collaborations, the Fourth International Blastocystis Conference was hosted from the 17 th to the 19 th of September 2024 in Heraklion (Crete, Greece). The event was mainly supported by the COST Action CA21105, “ Blastocystis under One Health”, and the Microbiology Society. The multi- and interdisciplinary conference programme covered all aspects related to Blastocystis evolutionary biology and advances in omics, intestinal ecology (gut microbiome), clinical significance and association with disease, diagnosis and molecular characterisation, as well as epidemiology and One Health. The high-quality presentations discussed at the conference provided researchers with a synthesis of recent advancements, while key research questions, knowledge gaps, and future steps in Blastocystis research were identified. Herein, we aim to provide a thorough overview of the presentations at the conference. The COST Action CA21105, “Blastocystis under One Health”, will build on the insights and collaborations fostered during the conference, promoting integrative research approaches, advancing our understanding of Blastocystis, and driving future efforts to translate these findings into improved public health strategies.

26 January 2026 in Journal of Eukaryotic Microbiology
Verified
Journal Article
Open access
DSDaisy Shaw
Daisy Shaw
EGEleni Gentekaki
Eleni Gentekaki
ATAnastasios D. Tsaousis
Anastasios D. Tsaousis
Blastocystis spp., one of the most prevalent microeukaryotes in the human gut, has long puzzled researchers with its ambiguous role in health and disease. Decades‐old microscopy studies reported bacterial‐ and viral‐like particles within Blastocystis spp. cells, but these findings have been mainly overlooked. Comparable associations in other protozoa, such as those between Trichomonas vaginalis and Mycoplasma , as well as protozoan–virus interactions, are known to influence metabolism, immune evasion, and ecological fitness. Here, we revisit these neglected observations in Blastocystis spp., framing them within the holobiont concept and proposing that this protist may host its own microbial consortium. We also propose potential mechanisms, ecological implications, and modern experimental strategies—from organ‐on‐a‐chip to single‐cell multi‐omics—to rigorously test this hypothesis. Recognizing Blastocystis spp. as a possible “microbiome within a microbe” could transform our understanding of its biology and its place in gut microbial ecology.

18 May 2026 in Open Research Europe
Verified
Journal Article
Open access
IKIliya Dauda Kwoji
Iliya Dauda Kwoji
WEWilliam Edwards
William Edwards
ARAbbey Ruffell
Abbey Ruffell
DSDaisy Shaw
Daisy Shaw
CDConstance Denoyelle
Constance Denoyelle
ATAnastasios D. Tsaousis
Anastasios D. Tsaousis
BlastoDB ( https://www.blastodb.com/) is developed as an open-access, community-driven resource dedicated to Blastocystis, one of the most common yet understudied intestinal protists. BlastoDB will offer the scientific community up-to-date, curated information on Blastocystis by integrating epidemiological data, microbiome profiles, multi-omics datasets (genomics, transcriptomics, proteomics, and metabolomics), reference sequences for subtypes, protocols, microscopy images, and related metadata. In this initial release, we describe the data model, database architecture, curation pipelines, and web interface, which together facilitate subtype classification, comparative and integrative analyses, and cross-study synthesis of epidemiological and experimental data. We outline submission and governance workflows designed to support community contributions, training activities, and sustainable curation under the “ Blastocystis under One Health” COST Action (CA21105). Finally, we highlight planned extensions, including expanded metagenomic and metatranscriptomic content, automated genome quality assessments, metagenome-assembled genomes, and geospatial and analytical dashboards. BlastoDB provides a central, FAIR-aligned hub for Blastocystis data, images, and protocols, reducing technical barriers and fostering a collaborative ecosystem for studying this globally prevalent protist.